• DOI:10.1111/j.1365-4632.2011.04871.x
Corpus ID: 21538173

TNF alpha antagonist‐induced lupus‐like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists

@article{Williams2011TNFAA,
  title={TNF alpha antagonist‐induced lupus‐like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists},
  author={Victoria L. Williams and Philip R. Cohen},
  journal={International Journal of Dermatology},
  year={2011},
  volume={50}
}

Victoria L. Williams, Philip R. Cohen

Published 2011

Medicine

International Journal of Dermatology

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed

Background  In patients with various autoimmune and rheumatic diseases, a drug‐induced lupus‐like syndrome (DILS) has been reported with the use of adalimumab, cerrolizumab pegol, etanercept, and infliximab.